Robert Hazlett
Robert Hazlett
billion change company critical growth
It's at the margin. It's $3 billion and change of a $50 billion company, so it's not inconsequential, but is it critical to the growth of the company going forward? No.
investors meaningful risk
For investors in Pfizer, this is a meaningful event. This risk has been a significant overhang for some time.
confidence hard inspiring looking pull
It's not very confidence inspiring to pull your guidance, and because of that we're looking hard at our 2006 estimates.
appears challenge knew
We knew 2003 was going to be a challenge, but it appears it's going to be more of a challenge than we expected.